A Chemokine Receptor Antagonist Inhibits Experimental Breast Tumor Growth

Cancer Research

Volumn 63, Issue 23, 2003, Pages 8360-8365

  Robinson, Stephen C ^a   Scott, Kate A ^a   Wilson, Julia L ^a   Thompson, Richard G ^a   Proudfoot, Amanda E I ^b   Balkwill, Frances R ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b SERONO PHARMACEUTICAL RES INSTITUTE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BETA CHEMOKINE; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR ANTAGONIST; CHEMOKINE RECEPTOR CCR1; CHEMOKINE RECEPTOR CCR5; COLLAGENASE; MET RANTES; RANTES; RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST TUMOR; CANCER PREVENTION; CARCINOGENESIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; INFLAMMATION; LYMPHOCYTIC INFILTRATION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; TUMOR GROWTH;

ANIMALS; CELL DIVISION; FEMALE; LYMPHOCYTES, TUMOR-INFILTRATING; MACROPHAGES; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED BALB C; RANTES; RECEPTORS, CCR5; RECEPTORS, CHEMOKINE; RNA, MESSENGER;

EID: 0346365367     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Balkwill, F., and Mantovani, A. Inflammation and cancer: back to Virchow? Lancet, 357: 539-545, 2001.
2. Mantovani, A., Sozzani, S., Locati, M., Allavena, P., and Sica, A. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol., 23: 549-555, 2002.
3. Wilson, J., and Balkwill, F. The role of cytokines in the epithelial cancer microenvironment. Semin. Cancer Biol., 12: 113-120, 2002.
4. Coussens, L. M., and Werb, Z. Inflammation and cancer. Nature (Lond.), 420: 860-867, 2002.
5. Lin, E. Y., Nguyen, A. V., Russell, R. G., and Pollard, J. W. Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy. J. Exp. Med., 193: 727-740, 2001.
6. Balkwill, F. Chemokine biology in cancer. Semin. Immunol., 15: 49-55, 2003.
7. Vicari, A. P., and Caux, C. Chemokines in cancer. Cytokine Growth Factor Rev., 13: 143-154, 2002.
8. Luboshits, G., Shina, S., Kaplan, O., Engelberg, S., Nass, D., Lifshitz-Mercer, B., Chaitchik, S., Keydar, I., and Ben-Baruch, A. Elevated expression of the CC chemokine regulated on activation, normal T cell expressed and secreted (RANTES) in advanced breast carcinoma. Cancer Res., 59: 4681-4687, 1999.
9. Azenshtein, E., Luboshits, G., Shina, S., Neumark, E., Shahbazian, D., Weil, M., Wigler, N., Keydar, I., and Ben-Baruch, A. The CC chemokine RANTES in breast carcinoma progression: regulation of expression and potential mechanisms of promalignant activity. Cancer Res., 62: 1093-1102, 2002.
10. Robinson, S. C., Scott, K. A., and Balkwill, F. R. Chemokine stimulation of monocyte matrix metalloproteinase-9 requires endogenous TNF-α. Eur. J. Immunol., 32: 404-412, 2002.
11. Plater-Zyberk, C., Hoogewerf, A. J., Proudfoot, A. E., Power, C. A., and Wells, T. N. Effect of a CC chemokine receptor antagonist on collagen induced arthritis in DBA/1 mice. Immunol. Lett., 57: 117-120, 1997.
12. Stumbles, P. A., Strickland, D. H., Pimm, C. L., Proksch, S. F., Marsh, A. M., McWilliam, A. S., Bosco, A., Tobagus, I., Thomas, J. A., Napoli, S., Proudfoot, A. E., Wells, T. N., and Holt, P. G. Regulation of dendritic cell recruitment into resting and inflamed airway epithelium: use of alternative chemokine receptors as a function of inducing stimulus. J. Immunol., 167: 228-234, 2001.
13. Chomczynski, P., and Sacchi, N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162: 156-159, 1987.
14. Mack, M., Cihak, J., Simonis, C., Luckow, B., Proudfoot, A. E., Plachy, J., Bruhl, H., Frink, M., Anders, H. J., Vielhauer, V., Pfirstinger, J., Stangassinger, M., and Schlondorff, D. Expression and characterization of the chemokine receptors CCR2 and CCR5 in mice. J. Immunol., 166: 4697-4704, 2001.
15. Lalani, E. N., Berdichevsky, F., Boshell, M., Shearer, M., Wilson, D., Stauss, H., Gendler, S. J., and Taylor-Papadimitriou, J. Expression of the gene coding for a human mucin in mouse mammary tumor cells can affect their tumorigenicity. J. Biol. Chem., 266: 15420-15426, 1991.
16. Muller, A., Homey, B., Soto, H., Ge, N., Catron, D., Buchanan, M. E., McClanahan, T., Murphy, E., Yuan, W., Wagner, S. N., Barrera, J. L., Mohar, A., Verastegui, E., and Zlotnik, A. Involvement of chemokine receptors in breast cancer metastasis. Nature (Lond.), 410: 50-56, 2001.
17. Scotton, C. J., Wilson, J. L., Milliken, D., Stamp, G., and Balkwill, F. R. Epithelial cancer cell migration: a role for chemokine receptors? Cancer Res., 61: 4961-4965, 2001.
18. Grone, H. J., Weber, C., Weber, K. S., Grone, E. F., Rabelink, T., Klier, C. M., Wells, T. N., Proudfood, A. E., Schlondorff, D., and Nelson, P. J. Met-RANTES reduces vascular and tubular damage during acute renal transplant rejection: blocking monocyte arrest and recruitment. FASEB J., 13: 1371-1383, 1999.
19. Matsui, M., Weaver, J., Proudfoot, A. E., Wujek, J. R., Wei, T., Richer, E., Trapp, B. D., Rao, A., and Ransohoff, R. M. Treatment of experimental autoimmune encephalomyelitis with the chemokine receptor antagonist Met-RANTES. J. Neuroimmunol., 128: 16-22, 2002.
20. Curtis, A. S. G. Area and volume measurements by random sampling methods. Med. Biol. Illus., 10: 261-266, 1960.
21. Dexter, D. L., Kowalski, H. M., Blazar, B. A., Fligiel, Z., Vogel, R., and Heppner, G. H. Heterogeneity of tumor cells from a single mouse mammary tumor. Cancer Res., 38: 3174-3181, 1978.
22. Camp, B. J., Dyhrman, S. T., Memoli, V. A., Mott, L. A., and Barth, R. J., Jr. In situ cytokine production by breast cancer tumor-infiltrating lymphocytes. Ann. Surg. Oncol., 3: 176-184, 1996.
23. Negus, R. P., Stamp, G. W., Hadley, J., and Balkwill, F. R. Quantitative assessment of the leukocyte infiltrate in ovarian cancer and its relationship to the expression of C-C chemokines. Am. J. Pathol., 150: 1723-1734, 1997.
24. Elgert, K. D., Alleva, D. G., and Mullins, D. W. Tumor-induced immune dysfunction: the macrophage connection. J. Leukoc. Biol., 64: 275-290, 1998.
25. Proudfoot, A. E., Power, C. A., Hoogewerf, A. J., Montjovent, M. O., Borlat, F., Offord, R. E., and Wells, T. N. Extension of recombinant human RANTES by the retention of the initiating methionine produces a potent antagonist. J. Biol. Chem., 271: 2599-2603, 1996.
26. Proudfoot, A. E., Buser, R., Borlat, F., Alouani, S., Soler, D., Offord, R. E., Schroder, J. M., Power, C. A., and Wells, T. N. Amino-terminally modified RANTES analogues demonstrate differential effects on RANTES receptors. J. Biol. Chem., 274: 32478-32485, 1999.
27. Huang, M. B., Khan, M., Garcia-Barrio, M., Powell, M., and Bond, V. C. Apoptotic effects in primary human umbilical vein endothelial cell cultures caused by exposure to virion-associated and cell membrane-associated HIV-1 gp120. J. Acquir. Immune. Defic. Syndr., 27: 213-221, 2001.